OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
6
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
Orbitrap Fusion Lumos
(1)
Q Exactive HF-X
(1)
Publication Date
2024
(1)
Release Date
2017
(3)
2020
(1)
2015
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Apolipoprotein A-II Increases Cholesterol Efflux Capacity of Mature High-Density Lipoproteins Via the Apolipoprotein A-I C-terminus
Samples were processed using Global and Limited Proteolysis (LiP). Peptides and proteins were identified using MaxQuant (v1.6.17.0), then summarized using R package RomicsProcessor.
ORGANISM(S):
Homo Sapiens (ncbitaxon:9606)
2024-07-29
|
MSV000095479
|
MassIVE
Cite
Recruitment of trial participants through electronic medical record patient portal messaging: A pilot study.
Not available
S-EPMC6992491
|
biostudies-literature
Cite
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Not available
S-EPMC4588097
|
biostudies-literature
Cite
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).
Not available
S-EPMC6195190
|
biostudies-literature
Cite
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.
Not available
S-EPMC5418564
|
biostudies-literature
Cite
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).
Not available
S-EPMC6195192
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets